U.S. CDC panel to vote on using Pfizer COVID-19 shot in adolescents
An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Wednesday to review data on the use of Pfizer Inc (PFE.N) and partner BioNTech’s (22UAy.DE) COVID-19 vaccine in adolescents aged 12 to 15.
Read More
Canada’s ex-finance minister breached ethics rules in charity dealings 
Judge axes employee wage claims, keeps others in Wawa data breach case